0.05 between groups). Four weeks later, LVEF had not changed in the CMP (37±3%) and PCB (32±2%) groups but had significantly increased in the ACB group (48±5%, p<0.05). LVEF was 23±4% in the controls (p<0.05 vs. all groups).Conclusion- Adaptive cardiac binding that gradually adapts to the heart's natural variations in tension and contractile strength is a promising new surgical approach for patients who have end-stage heart failure.
]]>
p. 5−14
Vol.7/No.2
p. 15−18
Vol.7/No.2
p. 19−24
Vol.7/No.2
p. 25−30
Vol.7/No.2
p. 31−36
Vol.7/No.2
p. 37−41
Vol.7/No.2
p. 42−43
Vol.7/No.2
p. 44−47
Vol.7/No.2